Isavuconazonium Sulfate
Brand name: Cresemba
Rank #432 of 500 drugs by total cost
$19.2M
Total Cost
3,050
Total Claims
$19.2M
Total Cost
157
Prescribers
$6,295
Cost per Claim
109
Beneficiaries
3,237
30-Day Fills
$122K
Avg Cost/Provider
19
Avg Claims/Provider
About Isavuconazonium Sulfate
Isavuconazonium Sulfate (sold as Cresemba) was prescribed 3,050 times by 157 Medicare Part D providers in 2023, costing the program $19.2M. At $6,295 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 429 | Darbepoetin Alfa In Polysorbat (Aranesp) | $19.3M | 6,889 |
| 430 | Ondansetron Hcl (Ondansetron Hcl) | $19.3M | 1,255,548 |
| 431 | Tasimelteon (Hetlioz) | $19.3M | 763 |
| 432 | Isavuconazonium Sulfate (Cresemba) | $19.2M | 3,050 |
| 433 | Paroxetine Hcl (Paroxetine Hcl) | $19.2M | 1,226,222 |
| 434 | Naloxone Hcl (Naloxone Hcl) | $19.0M | 232,875 |
| 435 | Elapegademase-Lvlr (Revcovi) | $19.0M | 52 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology